Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens. (Q47712334)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

0 references

object named as

S Emery

3

0 references

author name string

A D Kelleher

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

M Roggensack

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

A Carr

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

M A French

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

D A Cooper

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

publication date

1 July 1998

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

113

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

85-91

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Decreased T-cell proliferative response to common environmental antigens could be an indicator of early human immunodeficiency virus-mediated lymphocyte lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Comprehensive T-cell epitope mapping of HIV-1 env antigens reveals many areas recognized by HIV-1-seropositive and by low-risk HIV-1-seronegative individuals.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

HIV-1 peptides induce a proliferative response in lymphocytes from infected persons.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

T cell responses to peptides covering the gag p24 region of HIV -1 occur in HIV -1 seronegative individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905022

29 September 2018

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1998.00633.X

21 January 2018

Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1998.00633.X

21 January 2018

T cell recognition of HIV synthetic peptides in a natural infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9697988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired T-lymphocyte-dependent immune responses to microbial antigens in patients with HIV-1-associated persistent generalized lymphadenopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9697988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9697988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations

1 reference

https://pubmed.ncbi.nlm.nih.gov/9697988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/9697988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9697988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2249.1998.00633.X

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

0 references

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9697988

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47712334&oldid=1390006784"